Wells sees potential upside after Glaukos’ iDose repeat dosing label approved
Wells Fargo notes that Glaukos (GKOS) has announced FDA approval of its repeat dosing label for iDose, in line with ...
Monday, April 6, 2026
Tag: Glaukos
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.